We are live on ! Find out more
BI

BVF Inc Portfolio holdings

AUM $3.14B
1-Year Est. Return 249.53%
This Fund
S&P 500
This Quarter Est. Return
+19.33%
1 Year Est. Return
+249.53%
3 Year Est. Return
+690.11%
5 Year Est. Return
+1,011.36%
10 Year Est. Return
+22,702.25%
AUM
$2.67B
AUM Growth
+$125M
Cap. Flow
+$47M
Cap. Flow %
1.76%
Top 10 Hldgs %
52.29%
Holding
77
New
9
Increased
18
Reduced
19
Closed
10

Top Buys

Rank Stock Value
1
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$132M
2
ARGX icon
argenx
ARGX
+$78.1M
3
IMA
ImageneBio Inc
IMA
+$45.7M
4
CGEM icon
Cullinan Oncology
CGEM
+$42.6M
5
MRUS
Merus
MRUS
+$34.1M

Top Sells

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$101M
2
AMRN
Amarin Corp
AMRN
+$60.8M
3
XNCR icon
Xencor
XNCR
+$55.2M
4
ALXO icon
ALX Oncology
ALXO
+$46.6M
5
RCUS icon
Arcus Biosciences
RCUS
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 98.46%
2 Financials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSTX
76
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-25,844
Closed -$255K
PANA.U
77
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
– –
-9,837
Closed -$126K
1 2 3
4

Similar funds

GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return

BVF Inc's Q1 2021 Portfolio in Review

As of Q1 2021, BVF Inc held 77 positions worth $2.67B, up 4.9% from $2.54B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

BVF Inc's Q1 2021 filing shows 9 new, 18 increased, 19 reduced and 10 closed positions. Its largest new stake was ImageneBio Inc: 133,305 shares worth $45.2M. The largest sale was Cytokinetics, an estimated $101M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier, followed by Financials.

  • BVF Inc's largest Q1 2021 buy was ImageneBio Inc: 133,305 shares worth $45.2M.
  • BVF Inc added most to Five Prime Therapeutics, Inc. in Q1 2021, an estimated $132M increase.
  • BVF Inc's biggest Q1 2021 reduction was Amarin Corp, cutting an estimated $60.8M.
  • BVF Inc fully exited Cytokinetics in Q1 2021, selling an estimated $101M.
  • BVF Inc's ten largest holdings make up 52% of its $2.67B portfolio in Q1 2021.
  • BVF Inc opened 9 new positions and closed 10 in Q1 2021.
  • BVF Inc's portfolio value rose 4.9% quarter-over-quarter to $2.67B.

Based on BVF Inc's 13F filing for Q1 2021, filed 17 May 2021.